Characterization of a Phage Display-Derived Human Monoclonal Antibody (NHS76) Counterpart to Chimeric TNT-1 Directed Against Necrotic Regions of Solid Tumors-Reference-Cited by-同舟云学术

Characterization of a Phage Display-Derived Human Monoclonal Antibody (NHS76) Counterpart to Chimeric TNT-1 Directed Against Necrotic Regions of Solid Tumors

Published:2001-10 Issue:5-6 Volume:20 Page:305-312
ISSN:1536-8599
Container-title:Hybridoma and Hybridomics
language:en
Short-container-title:Hybridoma and Hybridomics

Author:

Sharifi Janhangir¹,Khawli Leslie A.¹,Hu Peisheng¹,King Steve²,Epstein Alan L.¹

Affiliation:

1. Department of Pathology, University of Southern California, Keck School of Medicine, Los Angeles, CA 90033

2. Peregrine Pharmaceuticals, Inc., Tustin, CA 92780

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/15368590152740707

Reference28 articles.

1. Humanized antibodies

2. By-passing immunization

3. By-passing immunisation

4. A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxic reactivation of Kaposi’s Sarcoma associated Herpesvirus;Cell Insight;2024-09

2. Tumor-Homing Antibody-Cytokine Fusions for Cancer Therapy;OncoTargets and Therapy;2024-08

3. Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocol;Journal of Gastrointestinal Oncology;2024-06

4. Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine;Frontiers in Oncology;2024-01-08

5. First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma;Journal for ImmunoTherapy of Cancer;2023-05